trending Market Intelligence /marketintelligence/en/news-insights/trending/e44dfcd_ieuhevzqnm_oqg2 content esgSubNav
In This List

OpGen regains compliance with Nasdaq listing requirements

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


OpGen regains compliance with Nasdaq listing requirements

OpGen Inc. said it regained compliance with Nasdaq's minimum bid price requirement and will continue to trade on the stock exchange.

The developer of laboratory tests added that it was in compliance with all of Nasdaq's applicable listing standards and so its hearing before the Nasdaq hearings panel has been canceled.

OpGen recently implemented a 1-for-25 reverse stock split to increase the per-share market price of its common stock in connection with Nasdaq regulations.